Much ado about something: a response to “COVID-19: underpowered randomised trials, or no randomised trials?”
Abstract Non-pharmaceutical interventions (NPI) for infectious diseases such as COVID-19 are particularly challenging given the complexities of what is both practical and ethical to randomize. We are often faced with the difficult decision between having weak trials or not having a trial at all. In...
Saved in:
Main Authors: | , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
BMC
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/acc80c986e95464cbc126642a8ed9314 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|